Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Tsqaltubos Raionuli Saa… | Healthcare Services | 52.2% | 99th pct | 268 |
| Sameditsino Sainvestits… | Healthcare Services | 11.5% | 56th pct | 268 |
| Hospital Service | Healthcare Services | -15.8% | 10th pct | 268 |
| Bavshvta Janmrtelobis T… | Healthcare Services | -23.7% | 7th pct | 268 |
| V. Sanikidzis Sakhelobi… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Hospital Service | Sameditsino Sainvestits… | Tsqaltubos Raionuli Saa… | Bavshvta Janmrtelobis T… | V. Sanikidzis Sakhelobi… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 61.3% | 53.9% | 49.5% | 88.2% | — |
| EBITDA Margin | -15.8% | 11.5% | 52.2% | -23.7% | — |
| EBITDAR | -197 | 164 | 739 | -335 | — |
| EBITDAR Margin | -13.7% | 11.5% | 52.2% | -23.7% | — |
| EBIT Margin | -48.9% | -42.2% | 46.1% | -32.3% | — |
| Net Profit Margin | -69.6% | -45.4% | 51.2% | -26.7% | — |
| Operating Expense % of Sales | 77.1% | 42.3% | 2.7% | 111.9% | — |
| Returns | |||||
| Return on Assets (ROA) | -11.3% | -10.4% | 9.4% | -24.7% | — |
| Return on Equity (ROE) | -38.2% | -104.5% | 11.3% | -33.0% | — |
| ROIC [EBIT / Invested Capital] | |||||
| -11.7% |
| -14.3% |
| 10.9% |
| -38.8% |
| — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 42.1% | 58.9% | 0.0% | 2.7% | — |
| Debt-to-Equity | 1.43x | 5.91x | 0.00x | 0.04x | — |
| Debt-to-EBITDA | N/A | 22.26x | 0.00x | N/A | — |
| Equity-to-Assets | 29.4% | 10.0% | 83.6% | 74.9% | — |
| Net Debt | 3,413 | 3,567 | -452 | 33 | — |
| Cash & Equivalents | 340 | 84 | 452 | 9 | — |
| Total Debt | 3,753 | 3,651 | N/A | 42 | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.93x | 0.95x | 2.17x | 1.03x | — |
| Quick Ratio | 0.93x | 0.95x | 2.17x | 1.03x | — |
| Cash Ratio | 0.15x | 0.04x | 0.36x | 0.02x | — |
| Total Current Assets | 2,091 | 1,882 | 2,736 | 396 | — |
| Total Current Liabilities | 2,253 | 1,988 | 1,258 | 384 | — |
| Inventory | N/A | N/A | N/A | N/A | — |
| Trade Receivables | 929 | 494 | 686 | 293 | — |
| Trade Payables | 2,533 | 1,913 | 1,078 | 42 | — |
| Net Working Capital | -162 | -106 | 1,478 | 11 | — |
| Net Working Capital % of Revenue | -11.3% | -7.5% | 104.5% | 0.8% | — |
| Trade Working Capital | -1,604 | -1,419 | -392 | 251 | — |
| Trade Working Capital % of Revenue | -111.4% | -99.7% | -27.7% | 17.8% | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | — |
| Receivables Turnover | 1.55x | 2.88x | 2.06x | 4.82x | — |
| Days Sales Outstanding (DSO) | 235.6 | 126.8 | 177.0 | 75.8 | — |
| Payables Turnover | 0.22x | 0.34x | 0.66x | 3.95x | — |
| Days Payable Outstanding (DPO) | 1659.5 | 1063.9 | 551.1 | 92.5 | — |
| Cash Conversion Cycle | -1423.9 days | -937.1 days | -374.1 days | -16.7 days | — |
| Asset Turnover | 0.16x | 0.23x | 0.18x | 0.92x | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 325 | 29 | 702 | -71 | — |
| Free Cash Flow (OCF − Capex proxy) | -7 | 29 | 441 | -72 | — |
| Cash Conversion (OCF / EBITDA) | N/A | 17.8% | 95.0% | N/A | — |
| Dividends Declared | N/A | N/A | N/A | N/A | — |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | — |